Should physicians prescribe metformin to women with polycystic ovary syndrome PCOS?;Rôle de la metformine dans le SOPK

Annales d'Endocrinologie

Volumn 71, Issue 1, 2010, Pages 25-27

  Duranteau, L ^a   Lefevre, P ^b   Jeandidier, N ^c   Simon, T ^d   Christin Maitre, S ^d  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c HÔPITAL CIVIL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

French consensus; Metformin; Polycystic ovary syndrome

Indexed keywords

ANTIDIABETIC AGENT; CLOMIFENE; FERTILITY PROMOTING AGENT; METFORMIN;

ADULT; BODY MASS; DIABETES MELLITUS; DRUG EFFECT; FEMALE; FEMALE INFERTILITY; HUMAN; HYPERANDROGENISM; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY DIABETES MELLITUS; REVIEW;

ADULT; BODY MASS INDEX; CLOMIPHENE; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; HYPERANDROGENISM; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; MENSTRUAL CYCLE; METFORMIN; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 77952300848     PISSN: 00034266     EISSN: 22133941     Source Type: Journal    
DOI: 10.1016/j.ando.2009.12.005     Document Type: Article

References (11)

1. Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop group. Hum Reprod 2004;19:41–7.
2. Costello, M., Shrestha, B., Eden, J., Sjoblom, P., Johnson, N., Insulin-sensitizing drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst Rev, 2007, CD005552.
3. Palomba, S., Falbo, A., Zullo, F., Orio, F., Evidence-based and potential benefits of metformin in polycystic ovary syndrome. Endocr Rev 30 (2009), 1–50.
4. Creanga, A.A., Bradley, H.M., McCormick, C., Witkop, C.T., Uses of metformin in polycystic ovary syndrome: a meta analysis. Obstet Gynecol 111 (2008), 959–968.
5. Palomba S, Falbo A, Orio F, Zullo F. Preconceptional effects of metformin on abortion risk in polycystic ovary syndrome (PCOS): a systematic review and meta-analysis of randomized controlled trials (RCTs). Fertil Steril 2008 epub ahead of print.
6. Fougner, K.J., Vanky, E., Carlsen, S.M., Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest 24 (2008), 1–6.
7. American Diabetes Association Standards for medical care in diabetes-2009 Diabetes Care 2009;32:13–61.
8. Lord, J.M., Flight, I.H., Norman, R.J., Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inosital) for polycystic ovary syndrome. Cochrane Database Syst Rev, 2003, CD003053.
9. Rizzo, M., Berneis, K., Spinas, G., Rini, G.B., Carmina, E., Long-term consequence of polycystic ovary syndrome on cardiovascular risk. Fertil Steril 91 (2009), 1563–1567.
10. Jovanovic VP, Carmina E, Lobo RA. Not all women diagnosed with PCOS share the same cardiovascular risk profile Fertil Steril 2009 June 4 epub ahead of print.
11. Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., Neil, H.A., 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008), 1577–1589.